Literature DB >> 13389375

[Activity of a new phenothiazine in psychiatry and neurology; therapeutic properties of 10-(3-dimethylamino-2-methyl-propyl)-3-methoxyphenothiazine].

D BOUTTIER, M HENNE, A QUETIN, C RAYMONDEAUD, J SIGWALD.   

Abstract

Entities:  

Keywords:  CENTRAL NERVOUS SYSTEM/diseases; PHENOTHIAZINE/related compounds

Mesh：

Substances：

Year:  1956        PMID： 13389375

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0032-7867            Impact factor:   1.228


× No keyword cloud information.
  5 in total

1.  A clinical evaluation of levomepromazine in anaesthesia.

Authors:  A ROMAGNOLI; M COHEN; M J DIAMOND
Journal:  Can Anaesth Soc J       Date:  1959-07

2.  The comparative pharmacology of some psychotropic drugs.

Authors:  E JACOBSEN
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

3.  Levomepromazine (nozinan)-a new neuroleptic agent for treatment of senile patients.

Authors:  J M HUOT; A C KRISTOF
Journal:  Can Med Assoc J       Date:  1959-10-01       Impact factor: 8.262

Review 4.  Trimipramine, anxiety, depression and sleep.

Authors:  J C Pecknold; L Luthe
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 5.  A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.

Authors:  Gareth J Sanger; Paul L R Andrews
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.